Skip to main content
OpenTrials
Completed

NCT Number: NCT04382417

Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden

The study will prospectively collect data from patients with Covid-19 admitted to the Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and laboratory characteristics will be recorded. Analysis of data to identify predictors of disease severity, mortality and treatment response.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Critical Illness Disease Attributes Infections Lung Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Intensive Care Unit, Västerås Hospital

Västerås, Västmanland County, 723 48, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to the Intensive Care Unit with biological samples positive for SARS-CoV-2.
  • Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease.

Exclusion criteria

  • None.

Treatment and study plan

observational study

Other

Not required

Primary outcomes

  1. All-cause mortality

    Time frame: At 90 days follow-up after admittance to Intensive Care

Secondary outcomes

  1. Hospital length of stay

    Time frame: Until 90 days after admittance to Intensive Care

  2. ICU length of stay

    Time frame: Until 90 days after admittance to Intensive Care

  3. Number of days on mechanical ventilation

    Time frame: Until 90 days after admittance to Intensive Care

  4. Number of patients receiving vasopressor support

    Time frame: Until 90 days after admittance to Intensive Care

  5. Number of patients receiving renal replacement therapy

    Time frame: Until 90 days after admittance to Intensive Care

  6. Patient characteristics

    Time frame: At admission to ICU

Sponsors and collaborators

Lead sponsor

Region Västmanland

Other

Registry information

Official study title

Characteristics and Outcomes of Critically Ill Patients With Covid-19 in a Large Swedish County Hospital - a Prospective Observational Cohort Study

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
May 11, 2020
Registry last updated
Mar 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.